StockClub
BBIOBridgeBio Pharma, Inc.$ --
BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.

BBIO

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
502M USD
YoY +126.3%

Operating Income

bar_chart
-569M USD
YoY +4.0%

Net Income

verified
-729M USD
YoY -36.1%

EPS

pie_chart
-3.79USD
YoY -31.6%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2026
Net Income Progress43%On Track
Revenue Progress194.5M
Revenue Forecast919.1M
Net Income Progress-164M
Net Income Forecast-381.5M

Income Statement Details

Item
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
502
28
474
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
478
0
555
1,071
-569
Interest expense
Income before tax
Income tax expense
Net income
53
-735
1
-729

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.